B3-03: A randomized multicenter phase III study of cetuximab (Erbitux®) in combination with Taxane/Carboplatin versus Taxane/Carboplatin alone as first-line treatment for patients with advanced/metastatic Non-small cell lung cancer (NSCLC)

作者：Thomas J. Lynch, Taral Patel, Luke Dreisbach, Michael McCleod, W. Heim, Hermann Robert, Paschold Eugene, Virginie Pautret, Martin R. Weber, Donald Woytowitz · 发表于：Journal of Thoracic Oncology · 年份：2007 · DOI：10.1097/01.jto.0000283155.03863.e7 · 被引用次数：84 · 研究领域：Lung Cancer Treatments and Mutations、Lung Cancer Research Studies、Lung Cancer Diagnosis and Treatment